All you need to get started with ETF selection and analysis. Create your account now →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
FMED ETF · Fidelity Disruptive Medicine ETF
The FMED Exchange Traded Fund (ETF) is provided by Fidelity. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
Last update 3/13/2026, 1:30 PM UTC
LIVE
CLOSED
This fund is part ofMultiple Trends1M perf.+0.21%
Last price
$24.09
1M perf.
-4.80%
1M flows
N/A
AuM
€49M
E/R
0.5%
Rating
Not rated
ESG Consensus®
FMED
$24.09
Performance & flows
December 15, 2025 → March 13, 2026
Create a free account to view the flows graph
FMED
$24.09
-12.31%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -4.80% | -12.31% | +1.79% | N/A | N/A | -8.15% | -11.10% | -11.10% | |
| Flows |
Key fund info
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
3/13/2026
$24.09
1D NAV change
-1.26%
Dividend policy
No. of holdings
65
Inception date
6/12/2023
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Investment Company
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The fund seeks long-term growth of capital. Normally investing at least 80% of assets in securities of disruptive medicine companies.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
CURE
1M perf.
-5.32%
E/R
0.35%
DOCG
1M perf.
-7.52%
E/R
0.49%
HTEC
1M perf.
-4.76%
E/R
0.8%
CIB0
1M perf.
-6.30%
E/R
0.55%
GDOC
1M perf.
-3.58%
E/R
0.75%
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -12.31% | +1.79% | N/A | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
89.20%
Belgium
3.98%
France
2.06%
Switzerland
1.39%
Canada
1.04%
Other
2.33%
Sectors
Health Care
82.23%
Unavailable
17.77%
Diversification
Total weight of top 15 holdings out of 65
Top 15 holdings
Data as of January 31, 2026
BOSTON SCIENTIFIC
DANAHER
US04016X1019
UCB
COGENT BIOSCIENCES
VEEVA SYSTEMS IN
PENUMBRA
ALNYLAM PHARMACEUTICALS
Create a free account to view top holdings
INTUITIVE SURGICAL
US9467841055
INSULET
LIFESTANCE HEALTH GROUP
EDWARDS LIFESCIENCES
MODERNA INC
STEDIM
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Fidelity
Fidelity ID Card
Number of funds
199
Total AuM
€173.95B
Expense ratio range
0.05% - 1.51%
Average expense ratio
0.4294%
Top 5 funds by Fidelity
| AuM | ||
|---|---|---|
FBND | Fidelity Total Bond ETF | €21.63B |
FTEC | Fidelity MSCI Information Technology Index ETF | €13.51B |
FBTC | Fidelity Wise Origin Bitcoin Fund | €11.58B |
ONEQ | Fidelity NASDAQ Composite Index ETF | €7.63B |
FDVV | Fidelity High Dividend ETF | €7.39B |
Frequently asked questions about FMED
What does Fidelity Disruptive Medicine ETF, FMED, invest in?
FMED is a Active ETF. This ETF provides exposure to Other Equities.
What is the Total Expense ratio (TER) of FMED?
FMED carries a total expense ratio (TER) of 0.5%, indicating the annual cost for holding the fund.
When was FMED launched?
FMED was introduced to the market on June 12, 2023. It trades on United States
Who is the ETF issuer of FMED?
Fidelity Disruptive Medicine ETF, FMED, is provided by Fidelity. Learn more about Fidelity here.
What is the current assets under management (AUM) of FMED?
FMED oversees €49M in assets as of March 13, 2026.
How has FMED performed lately?
Based on data from March 13, 2026, FMED returned -4.80% over the past month, -12.31% over the last three months and -11.10% year-to-date.
Does FMED distribute dividends?
FMED follows a distributing dividend policy, meaning it pays out income to investors.
What are the main country or region exposures of FMED?
As of January 31, 2026, FMED has significant geographic allocations in USA, Belgium and France.
In which sector or theme does FMED invest in?
As of January 31, 2026, FMED focuses largely on Health Care.
How many securities does FMED hold and how diversified is it?
As of January 31, 2026, FMED holds 65 positions in its portfolio, with 47.79% of assets concentrated in its top 15 holdings.
What are the main positions in FMED?
As of January 31, 2026, FMED top three holdings include BOSTON SCIENTIFIC, DANAHER and US04016X1019.
What is the base currency of FMED?
The base currency of FMED is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
